Actively Recruiting
Brief Admission by Self-referral for Individuals With Self-harm: Effects on Compulsory Care
Led by Region Skane · Updated on 2025-08-14
7000
Participants Needed
4
Research Sites
798 weeks
Total Duration
On this page
Sponsors
R
Region Skane
Lead Sponsor
L
Lund University
Collaborating Sponsor
AI-Summary
What this Trial Is About
Brief Admission by self-referral (BA) is a standardized treatment model, providing patient-controlled and person-centered care. It was developed to reduce self-harm and compulsory care by promoting autonomy. Randomized clinical trials have not yielded significant between group differences with respect to inpatient care, including compulsory care. The major difficulty in evaluating BA is preventing the control group from cross-contamination, as in the implementation process of BA, all physicians, all inpatient and outpatient staff as well as managers need to be informed and undergo basic education regarding the intervention. As BA addresses a prevalent and frustrating issue in psychiatric health care, there is considerable risk that the approach leaks to the control group, reducing the possibility to detect between-group differences. In the current study this will be addressed through a register-based approach, comparing similar clinics, implementing BA at different timepoints over time. Individuals with traits of borderline personality disorder will be included and comparisons will be made with respect to compulsory care, voluntary inpatient care and mortality.
CONDITIONS
Official Title
Brief Admission by Self-referral for Individuals With Self-harm: Effects on Compulsory Care
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Living in the uptake area of Lund, Linköping, Helsingborg or Norrköping
- Age 18-65 years at the time of inclusion
- Admitted to hospital with ICD-10 diagnosis borderline personality disorder (BPD) F60.3, or admitted at least twice with intentional self-harm (X60-83) combined with one or more of the following diagnoses: ADHD (F90.0-F90.X), bipolar disorder type 2 (F31.8W, F318A-F, F31.0, F31.8-9, F31.8W), autism, atypical autism, Asperger's syndrome (F84.0, F84.1, F84.5), or mild intellectual disability (F70.0-F70.9)
You will not qualify if you...
- Not fulfilling the inclusion criteria
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
Division of Psychiatry, Region Skåne
Lund, Skåne County, Sweden, 22185
Actively Recruiting
2
Region Östergötland
Linköping, Sweden, 581 91
Actively Recruiting
3
Statistiska centralbyrån
Solna, Sweden, 171 54
Actively Recruiting
4
Socialstyrelsen
Stockholm, Sweden, SE-106 30
Actively Recruiting
Research Team
S
Sofie Sofie, PhD
CONTACT
J
Josefin Vikström Eckevall, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
12
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here